Home COVID-19 Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients

Sunday, July 5, 2020

Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients

COVID-19
Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients submitted by /u/mkmyers45
[link] [comments]

Artikel Terkait

Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients
4/ 5
Oleh
Komentar

Berlangganan

Suka dengan artikel di atas? Silakan berlangganan gratis via email


EmoticonEmoticon